id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-D-0376-2015,FDA,FDA-2011-D-0376,Policy Regarding Quantitative Labeling of Dietary Supplements Containing Live Microbials; Draft Guidance for Industry; Availability,Notice,Notice of Availability,2018-09-07T04:00:00Z,2018,9,2018-09-07T04:00:00Z,2018-11-07T04:59:59Z,2018-11-08T02:04:07Z,2018-19367,0,0,09000064836bb54f
FDA-2011-D-0376-2016,FDA,FDA-2011-D-0376,Policy Regarding Quantitative Labeling of Dietary Supplements Containing Live Microbials: Guidance for Industry; Draft Guidance,Other,Guidance,2018-09-07T04:00:00Z,2018,9,2018-09-07T04:00:00Z,,2024-11-07T01:36:59Z,,1,0,09000064836bce73
FDA-2011-D-0376-2013,FDA,FDA-2011-D-0376,"Supplemental Comment from Susan Brienza, Esq. and P. Scott Polisky, Esq. (Jarrow Formulas, Inc.)",Other,Supplemental Comment,2017-05-25T04:00:00Z,2017,5,2017-05-25T04:00:00Z,,2017-05-25T18:32:45Z,,0,0,0900006482613537
FDA-2011-D-0376-2012,FDA,FDA-2011-D-0376,Attachment 1 Comments from Various Organization in Reference to New Dietary Ingredient Notifications and Related Issues re: Comment from Thorne Research,Supporting & Related Material,Background Material,2016-12-30T05:00:00Z,2016,12,,,2016-12-30T16:17:33Z,,0,0,0900006482441f42
FDA-2011-D-0376-1944,FDA,FDA-2011-D-0376,Request to Extend Comment Period from American College for Advancement in Medicine,Other,Request for Extension,2016-11-04T04:00:00Z,2016,11,2016-11-04T04:00:00Z,,2016-11-04T15:21:50Z,,0,0,090000648236b3dd
FDA-2011-D-0376-1943,FDA,FDA-2011-D-0376,Request to Extend Comment Period from Academic Collaborative for Integrative Health,Other,Request for Extension,2016-11-04T04:00:00Z,2016,11,2016-11-04T04:00:00Z,,2016-11-04T15:17:55Z,,0,0,090000648236b0dd
FDA-2011-D-0376-1922,FDA,FDA-2011-D-0376,Request for Extension from Mark Burger,Other,Request for Extension,2016-10-20T04:00:00Z,2016,10,2016-10-20T04:00:00Z,,2016-10-20T19:03:10Z,,0,0,0900006482296db5
FDA-2011-D-0376-1930,FDA,FDA-2011-D-0376,"Request for Extension from Dr. Moses Goldberg, ND",Other,Request for Extension,2016-10-20T04:00:00Z,2016,10,2016-10-20T04:00:00Z,,2016-10-20T19:35:38Z,,0,0,090000648229dbc6
FDA-2011-D-0376-1934,FDA,FDA-2011-D-0376,Request for Extension from Suzanne Leonard,Other,Request for Extension,2016-10-20T04:00:00Z,2016,10,2016-10-20T04:00:00Z,,2016-10-20T19:45:12Z,,0,0,09000064822d006f
FDA-2011-D-0376-1928,FDA,FDA-2011-D-0376,Request for Extension from Janis Randall,Other,Request for Extension,2016-10-20T04:00:00Z,2016,10,2016-10-20T04:00:00Z,,2016-10-20T19:29:57Z,,0,0,090000648229d80f
FDA-2011-D-0376-1932,FDA,FDA-2011-D-0376,Request for Extension from Clasina Leslie Smith,Other,Request for Extension,2016-10-20T04:00:00Z,2016,10,2016-10-20T04:00:00Z,,2016-10-20T19:38:38Z,,0,0,09000064822a72b4
FDA-2011-D-0376-1933,FDA,FDA-2011-D-0376,Request for Extension from Michael Levin,Other,Request for Extension,2016-10-20T04:00:00Z,2016,10,2016-10-20T04:00:00Z,,2016-10-20T19:43:08Z,,0,0,09000064822add25
FDA-2011-D-0376-1926,FDA,FDA-2011-D-0376,Request for Extension from Brad White,Other,Request for Extension,2016-10-20T04:00:00Z,2016,10,2016-10-20T04:00:00Z,,2016-10-20T19:28:28Z,,0,0,090000648229999e
FDA-2011-D-0376-1921,FDA,FDA-2011-D-0376,Request for Extension from Mark Smith,Other,Request for Extension,2016-10-20T04:00:00Z,2016,10,2016-10-20T04:00:00Z,,2016-10-20T18:51:40Z,,0,0,0900006482296224
FDA-2011-D-0376-1924,FDA,FDA-2011-D-0376,Request for Extension from Robert Wood,Other,Request for Extension,2016-10-20T04:00:00Z,2016,10,2016-10-20T04:00:00Z,,2016-10-20T19:04:03Z,,0,0,0900006482297e17
FDA-2011-D-0376-1923,FDA,FDA-2011-D-0376,Request for Extension from Clark Hansen,Other,Request for Extension,2016-10-20T04:00:00Z,2016,10,2016-10-20T04:00:00Z,,2016-10-20T19:03:15Z,,0,0,09000064822978b9
FDA-2011-D-0376-1916,FDA,FDA-2011-D-0376,Request to Extend Comment Period from Les Peterson,Other,Request for Extension,2016-10-18T04:00:00Z,2016,10,2016-10-18T04:00:00Z,,2016-10-18T18:46:57Z,,0,0,090000648229cf95
FDA-2011-D-0376-1910,FDA,FDA-2011-D-0376,Request to Extend Comment Period from Matthew Rycyk,Other,Request for Extension,2016-10-18T04:00:00Z,2016,10,2016-10-18T04:00:00Z,,2016-10-18T18:45:30Z,,0,0,09000064822831a6
FDA-2011-D-0376-1919,FDA,FDA-2011-D-0376,Request to Extend Comment Period from Crabtree Internal & Integrative Medicine,Other,Request for Extension,2016-10-18T04:00:00Z,2016,10,2016-10-18T04:00:00Z,,2016-10-18T18:51:19Z,,0,0,090000648231344d
FDA-2011-D-0376-1913,FDA,FDA-2011-D-0376,Request to Extend Comment Period from Arthur LeVine,Other,Request for Extension,2016-10-18T04:00:00Z,2016,10,2016-10-18T04:00:00Z,,2016-10-18T18:46:17Z,,0,0,090000648229818d
FDA-2011-D-0376-1915,FDA,FDA-2011-D-0376,Request to Extend Comment Period from Simla Somturk,Other,Request for Extension,2016-10-18T04:00:00Z,2016,10,2016-10-18T04:00:00Z,,2016-10-18T18:46:45Z,,0,0,090000648229cdb1
FDA-2011-D-0376-1912,FDA,FDA-2011-D-0376,Request to Extend Comment Period from Valori Treloar,Other,Request for Extension,2016-10-18T04:00:00Z,2016,10,2016-10-18T04:00:00Z,,2016-10-18T18:46:05Z,,0,0,09000064822940ee
FDA-2011-D-0376-1909,FDA,FDA-2011-D-0376,Request to Extend Comment Period from Rhonda Marcus,Other,Request for Extension,2016-10-18T04:00:00Z,2016,10,2016-10-18T04:00:00Z,,2016-10-18T16:34:27Z,,0,0,090000648229928c
FDA-2011-D-0376-1908,FDA,FDA-2011-D-0376,Request to Extend Comment Period from Michael D Levin,Other,Request for Extension,2016-10-18T04:00:00Z,2016,10,2016-10-18T04:00:00Z,,2016-12-30T15:44:46Z,,0,0,090000648228eb27
FDA-2011-D-0376-1914,FDA,FDA-2011-D-0376,Request to Extend Comment Period from Ralph Sanchez,Other,Request for Extension,2016-10-18T04:00:00Z,2016,10,2016-10-18T04:00:00Z,,2016-10-18T18:46:31Z,,0,0,090000648229978c
FDA-2011-D-0376-1918,FDA,FDA-2011-D-0376,Request to Extend Comment Period from Sarah Bartle,Other,Request for Extension,2016-10-18T04:00:00Z,2016,10,2016-10-18T04:00:00Z,,2016-10-18T18:47:26Z,,0,0,09000064822a72f0
FDA-2011-D-0376-1917,FDA,FDA-2011-D-0376,Request to Extend Comment Period from Henry Mouton,Other,Request for Extension,2016-10-18T04:00:00Z,2016,10,2016-10-18T04:00:00Z,,2016-10-18T18:47:13Z,,0,0,09000064822a0fc4
FDA-2011-D-0376-1911,FDA,FDA-2011-D-0376,Request to Extend Comment Period from Melissa Kerr,Other,Request for Extension,2016-10-18T04:00:00Z,2016,10,2016-10-18T04:00:00Z,,2016-10-18T18:45:51Z,,0,0,09000064822940bf
FDA-2011-D-0376-1893,FDA,FDA-2011-D-0376,"Dietary Supplements: New Dietary Ingredient Notifications and Related
Issues; Revised Draft Guidance for Industry; Extension of Comment Period",Notice,Extension of Comment Period,2016-10-04T04:00:00Z,2016,10,2016-10-04T04:00:00Z,2016-12-13T04:59:59Z,2018-01-27T02:01:51Z,2016-23931,0,0,0900006482291326
FDA-2011-D-0376-1885,FDA,FDA-2011-D-0376,Request to Extend Comment Period from Liane Owen,Other,Request for Extension,2016-09-29T04:00:00Z,2016,9,2016-08-12T04:00:00Z,2016-10-12T03:59:59Z,2016-10-22T20:26:25Z,,0,0,090000648226e9a5
FDA-2011-D-0376-1884,FDA,FDA-2011-D-0376,Request to Extend Comment Period from Eric Yarnell,Other,Request for Extension,2016-09-29T04:00:00Z,2016,9,2016-09-29T04:00:00Z,,2016-09-29T13:10:27Z,,0,0,090000648226e521
FDA-2011-D-0376-1892,FDA,FDA-2011-D-0376,Request to Extend Comment Period from Sherman L. Cohn,Other,Request for Extension,2016-09-29T04:00:00Z,2016,9,2016-09-29T04:00:00Z,,2016-09-29T13:19:07Z,,0,0,090000648227cc1b
FDA-2011-D-0376-1854,FDA,FDA-2011-D-0376,Request to Extend Comment Period from Alliance for Natural Health USA,Other,Request for Extension,2016-09-29T04:00:00Z,2016,9,2016-09-29T04:00:00Z,,2016-09-29T12:27:50Z,,0,0,090000648225c0b3
FDA-2011-D-0376-1871,FDA,FDA-2011-D-0376,Request to Extend Comment Period from Margaret Knapp,Other,Request for Extension,2016-09-29T04:00:00Z,2016,9,2016-08-12T04:00:00Z,2016-10-12T03:59:59Z,2016-09-29T12:45:09Z,,0,0,0900006482261de6
FDA-2011-D-0376-1864,FDA,FDA-2011-D-0376,Request to Extend Comment Period from June Meymand,Other,Request for Extension,2016-09-29T04:00:00Z,2016,9,2016-08-12T04:00:00Z,2016-10-12T03:59:59Z,2016-09-29T12:39:56Z,,0,0,0900006482261ba3
FDA-2011-D-0376-1870,FDA,FDA-2011-D-0376,Request to Extend Comment Period from Heidi Schor,Other,Request for Extension,2016-09-29T04:00:00Z,2016,9,2016-08-12T04:00:00Z,2016-10-12T03:59:59Z,2016-09-29T12:44:05Z,,0,0,0900006482261dc8
FDA-2011-D-0376-1872,FDA,FDA-2011-D-0376,Request to Extend Comment Period from Bruce Sims,Other,Request for Extension,2016-09-29T04:00:00Z,2016,9,2016-09-29T04:00:00Z,,2016-09-29T12:46:40Z,,0,0,0900006482261dfa
FDA-2011-D-0376-1877,FDA,FDA-2011-D-0376,Request to Extend Comment Period from Tracy Snipes,Other,Request for Extension,2016-09-29T04:00:00Z,2016,9,2016-09-29T04:00:00Z,,2016-09-29T12:52:40Z,,0,0,0900006482267b1b
FDA-2011-D-0376-1880,FDA,FDA-2011-D-0376,Request to Extend Comment Period from Oregon College of Oriental Medicine,Other,Request for Extension,2016-09-29T04:00:00Z,2016,9,2016-09-29T04:00:00Z,,2016-09-29T12:57:11Z,,0,0,0900006482269a8c
FDA-2011-D-0376-1891,FDA,FDA-2011-D-0376,Request to Extend Comment Period from United Natural Products Alliance (UNPA),Other,Request for Extension,2016-09-29T04:00:00Z,2016,9,2016-09-29T04:00:00Z,,2016-09-29T13:18:42Z,,0,0,090000648227cbc7
FDA-2011-D-0376-1883,FDA,FDA-2011-D-0376,Request to Extend Comment Period from Kris Justesen,Other,Request for Extension,2016-09-29T04:00:00Z,2016,9,2016-08-12T04:00:00Z,2016-10-12T03:59:59Z,2016-09-29T13:08:31Z,,0,0,090000648226e505
FDA-2011-D-0376-1873,FDA,FDA-2011-D-0376,"Request to Extend Comment Period from David Otto, NA",Other,Request for Extension,2016-09-29T04:00:00Z,2016,9,2016-09-29T04:00:00Z,,2016-09-29T12:47:38Z,,0,0,090000648226473b
FDA-2011-D-0376-1886,FDA,FDA-2011-D-0376,Request to Extend Comment Period from International Food Additives Council,Other,Request for Extension,2016-09-29T04:00:00Z,2016,9,2016-09-29T04:00:00Z,,2016-09-29T13:13:54Z,,0,0,0900006482274a5a
FDA-2011-D-0376-1882,FDA,FDA-2011-D-0376,"Request to Extend Comment Period from Flora Research Laboratories, LLC",Other,Request for Extension,2016-09-29T04:00:00Z,2016,9,2016-09-29T04:00:00Z,,2016-09-29T13:05:57Z,,0,0,090000648226d3f0
FDA-2011-D-0376-1881,FDA,FDA-2011-D-0376,Request to Extend Comment Period from M. Ellen,Other,Request for Extension,2016-09-29T04:00:00Z,2016,9,2016-09-29T04:00:00Z,,2016-09-29T13:00:27Z,,0,0,090000648226ce39
FDA-2011-D-0376-1866,FDA,FDA-2011-D-0376,Request to Extend Comment Period from K'Renee Simmons,Other,Request for Extension,2016-09-29T04:00:00Z,2016,9,2016-08-12T04:00:00Z,2016-10-12T03:59:59Z,2016-09-29T12:42:23Z,,0,0,0900006482261ce4
FDA-2011-D-0376-1889,FDA,FDA-2011-D-0376,Request to Extend Comment Period from Rachel Chevalier,Other,Request for Extension,2016-09-29T04:00:00Z,2016,9,2016-09-29T04:00:00Z,,2016-09-29T13:17:10Z,,0,0,0900006482278db4
FDA-2011-D-0376-1876,FDA,FDA-2011-D-0376,Request to Extend Comment Period from David Miller,Other,Request for Extension,2016-09-29T04:00:00Z,2016,9,2016-09-29T04:00:00Z,,2016-09-29T12:51:32Z,,0,0,09000064822677c2
FDA-2011-D-0376-1865,FDA,FDA-2011-D-0376,Request to Extend Comment Period from Jerry Segers,Other,Request for Extension,2016-09-29T04:00:00Z,2016,9,2016-08-12T04:00:00Z,2016-10-12T03:59:59Z,2016-09-29T12:41:16Z,,0,0,09000064822617f7
FDA-2011-D-0376-1837,FDA,FDA-2011-D-0376,Request to Extend Comment Period from Enzyme Technical Association,Other,Request for Extension,2016-09-29T04:00:00Z,2016,9,2016-09-29T04:00:00Z,,2016-09-29T12:11:43Z,,0,0,090000648221465b
FDA-2011-D-0376-1670,FDA,FDA-2011-D-0376,Request for Extension from Global Organization For EPA and DHA Omega-3s (GOED),Other,Request for Extension,2016-09-01T04:00:00Z,2016,9,2016-09-01T04:00:00Z,,2016-09-01T15:47:44Z,,0,0,09000064821bb28d
FDA-2011-D-0376-1668,FDA,FDA-2011-D-0376,Request for Extension from Consumer Healthcare Products Association (CHPA),Other,Request for Extension,2016-08-31T04:00:00Z,2016,8,2016-08-31T04:00:00Z,,2016-08-31T14:30:29Z,,0,0,09000064821b27e4
FDA-2011-D-0376-1667,FDA,FDA-2011-D-0376,Request to Extend Comment Period from American Herbal Products Association,Other,Request for Extension,2016-08-29T04:00:00Z,2016,8,2016-08-29T04:00:00Z,,2016-08-29T15:34:55Z,,0,0,09000064821a94b6
FDA-2011-D-0376-1664,FDA,FDA-2011-D-0376,Request for Extension from Natural Products Association,Other,Request for Extension,2016-08-25T04:00:00Z,2016,8,2016-08-25T04:00:00Z,,2016-08-25T15:38:21Z,,0,0,090000648219a19a
FDA-2011-D-0376-1663,FDA,FDA-2011-D-0376,Request for Extension from Council for Responsible Nutrition,Other,Request for Extension,2016-08-25T04:00:00Z,2016,8,2016-08-25T04:00:00Z,,2016-08-25T15:31:16Z,,0,0,09000064821984c4
FDA-2011-D-0376-1650,FDA,FDA-2011-D-0376,"Dietary Supplements: New Dietary Ingredient Notifications and Related
Issues; Revised Draft Guidance for Industry; Availability",Notice,Notice of Availability,2016-08-12T04:00:00Z,2016,8,2016-08-12T04:00:00Z,2016-10-12T03:59:59Z,2016-10-20T01:01:09Z,2016-19306,0,0,09000064821709ab
FDA-2011-D-0376-1561,FDA,FDA-2011-D-0376,"Jarrow Formulas, Inc. (P. Scott Polisky, Esq.) - Request for Extension",Other,Request for Extension,2013-05-23T04:00:00Z,2013,5,2013-05-23T04:00:00Z,,2013-05-23T22:44:18Z,,0,0,09000064812f5cab
FDA-2011-D-0376-1018,FDA,FDA-2011-D-0376,Natural Products Association (NPA) - Supplement,Other,Supplement (SUP),2012-09-25T04:00:00Z,2012,9,2012-09-25T04:00:00Z,,2012-09-25T16:11:23Z,,0,0,090000648110c1f3
FDA-2011-D-0376-0892,FDA,FDA-2011-D-0376,"Jarrow Formulas, Inc. (P. Scott Polisky, Esq.) - Letter re FDA-2011-D-0376-1561",Other,Letter(s),2012-07-16T04:00:00Z,2012,7,2012-07-16T04:00:00Z,,2013-05-23T22:45:19Z,,0,0,090000648101f297
FDA-2011-D-0376-0319,FDA,FDA-2011-D-0376,"Memorandum of Meeting with the Council for Responsible Nutrition (CRN), Consumer Healthcare Products Association (CHPA) and FDA/CFSAN",Other,Memorandum,2012-03-23T04:00:00Z,2012,3,2012-03-23T04:00:00Z,,2012-03-23T19:37:38Z,,0,0,0900006480fdfb44
FDA-2011-D-0376-0318,FDA,FDA-2011-D-0376,Council for Responsible Nutrition (CRN) - Request for Meeting,Other,Letter(s),2012-03-23T04:00:00Z,2012,3,2012-03-23T04:00:00Z,,2012-03-23T19:24:39Z,,0,0,0900006480fdfb42
FDA-2011-D-0376-0085,FDA,FDA-2011-D-0376,FDA/Office of Legislation Response to the Honorable Jon Kyl - Answer,Other,Answer,2011-10-20T04:00:00Z,2011,10,2011-10-20T04:00:00Z,,2011-10-20T19:21:30Z,,0,0,0900006480f5171c
FDA-2011-D-0376-0087,FDA,FDA-2011-D-0376,FDA/Office of Legislation Response to the Honorable Richard G. Lugar - Answer,Other,Answer,2011-10-20T04:00:00Z,2011,10,2011-10-20T04:00:00Z,,2011-10-20T19:37:04Z,,0,0,0900006480f572cd
FDA-2011-D-0376-0088,FDA,FDA-2011-D-0376,FDA/Office of Legislation Response to the Honorable Mark S. Kirk - Answer,Other,Answer,2011-10-20T04:00:00Z,2011,10,2011-10-20T04:00:00Z,,2011-10-20T19:36:18Z,,0,0,0900006480f572f4
FDA-2011-D-0376-0086,FDA,FDA-2011-D-0376,FDA/Office of Legislation Response to the Honorable Peter J. Visclosky - Answer,Other,Answer,2011-10-20T04:00:00Z,2011,10,2011-10-20T04:00:00Z,,2011-10-20T19:28:28Z,,0,0,0900006480f572cc
FDA-2011-D-0376-0084,FDA,FDA-2011-D-0376,The Honorable Frank R. Wolf to the Division of Dockets Management - Letter,Other,Letter(s),2011-10-13T04:00:00Z,2011,10,2011-10-13T04:00:00Z,,2013-07-28T00:05:30Z,,0,0,0900006480f51782
FDA-2011-D-0376-0080,FDA,FDA-2011-D-0376,"Jarrow Formulas, Inc. (P. Scott Polisky, Esq.) - Request for Extension",Other,Request for Extension,2011-09-12T04:00:00Z,2011,9,2011-09-12T04:00:00Z,,2013-05-23T22:54:00Z,,0,0,0900006480f0d055
FDA-2011-D-0376-0079,FDA,FDA-2011-D-0376,Draft Guidance for Industry; Dietary Supplements: New Dietary Ingredient Notifications and Related Issues; Availability; Extension of Comment Period,Notice,Extension of Comment Period,2011-09-09T04:00:00Z,2011,9,2011-09-09T04:00:00Z,2011-12-03T04:59:59Z,2014-04-30T01:03:00Z,2011-23098,0,0,0900006480f14cd9
FDA-2011-D-0376-0064,FDA,FDA-2011-D-0376,"American Herbal Products Association (AHPA), Consumer Healthcare Products Association (CHPA), Council for Responsible Nutrition (CRN), Natural Products Association (NPA), and United Natural Products Alliance (UNPA) - Request for Extension",Other,Request for Extension,2011-08-30T04:00:00Z,2011,8,2011-08-30T04:00:00Z,,2011-08-30T23:24:16Z,,0,0,0900006480ed8d24
FDA-2011-D-0376-0002,FDA,FDA-2011-D-0376,Draft Guidance for Industry; Dietary Supplements: New Dietary Ingredient Notifications and Related Issues,Other,Guidance,2011-07-05T04:00:00Z,2011,7,2011-07-05T04:00:00Z,,2020-06-02T17:32:17Z,,0,0,0900006480eb90bf
FDA-2011-D-0376-0001,FDA,FDA-2011-D-0376,Draft Guidance for Industry; Dietary Supplements; Availability: New Dietary Ingredient Notifications and Related Issues,Notice,Notice of Availability,2011-07-05T04:00:00Z,2011,7,2011-07-05T04:00:00Z,2011-10-04T03:59:59Z,2011-09-01T13:32:54Z,2011-16711,0,0,0900006480eb9610